Director dealings: Oxford Biodynamics interim chairman ups stake
11th Dec 2019 16:11
(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-listed biotechnology firm.
Read moreThree AIM firms celebrate Queen's Award for Enterprise wins
23rd Apr 2019 10:33
(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.
Read moreOxford BioDynamics biomarker to be used in prostate cancer test trial
19th Mar 2019 11:43
(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based diagnosis of prostate cancer in the 'PROSTAGRAM' trial.
Read moreOxford BioDynamics sets sights on China following GL investment
22nd Aug 2018 08:39
(Sharecast News) - AIM-listed biotechnology company Oxford BioDynamics has launched a strategic partnership with GL Capital, a Chinese healthcare-focused investment group.
Read more